CDRH Launches ‘Health Of Women’ Program; Research Agenda To Focus On Ortho, Cardio Devices
This article was originally published in The Pink Sheet Daily
Executive Summary
The device center plans to develop a research roadmap to explore sex-based differences in outcomes to musculoskeletal and cardiovascular disease devices, as well as devices targeting diseases specific to women. CDRH launched the effort as part of its new “Health of Women” initiative at a June 24-25 workshop.
You may also be interested in...
More Patients Should Receive Cardiac Resynchronization Therapy, Heart Groups Say
In revised practice guidelines released Sept. 10, the American Heart Association, the Heart Rhythm Society and the American College of Cardiology Foundation say new evidence shows that many patients with mild heart failure can benefit from cardiac resynchronization devices.
Study Finds Heart Device Trials Male-Dominated; FDA Promises Guidance
Women remain underrepresented in pivotal studies of cardiac devices submitted to FDA, and there is a lack of analysis distinguishing between trial outcomes in men and women, researchers conclude in a study published online March 1.
FDA Panel Endorses Expanded Approval For Boston Scientific CRT-Ds
Boston Scientific's cardiac resynchronization therapy defibrillators (CRT-Ds) should be approved for use in some healthier heart failure patients, though not quite as many as the company initially proposed, an FDA advisory panel said March 18